Trans-scleral krypton laser cyclophotocoagulation: Our experience of its use on patients with neovascular glaucoma

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Trans-scleral cyclophotocoagulation is an efficacious method in neovascular glaucoma (NVG) treatment. We have used it with krypton laser on 12 eyes of 12 patients affected by NVG with algetic symptoms. Six months after treatment, intraocular pressure was down enough for the pain to disappear. Executional simplicity and the possibility of modulating the intensity of the treatment are grounds for the encouragement of the technique's use in NVG.

Cite

CITATION STYLE

APA

Di Staso, S., Genitti, G., Verolino, M., Sepe, M., Scupola, A., & Balestrazzi, E. (1997). Trans-scleral krypton laser cyclophotocoagulation: Our experience of its use on patients with neovascular glaucoma. In Acta Ophthalmologica Scandinavica, Supplement (Vol. 75, pp. 37–38). https://doi.org/10.1111/j.1600-0420.1997.tb00467.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free